Subject: Nasdaq Composite Index Drops 0.44% 
Date: Published: 1/3/91 (25 lines)
Source: Wall Street Journal. Copyright Dow Jones & Co. Inc.

    OTC Focus:
    Nasdaq Composite Index Drops 0.44%
    As Late Sell-Off Deepens Early Losses
    ----
    By Dave Pettit
    Staff Reporter of The Wall Street Journal

[45 lines irrelevant to AIDS have been omitted.  -- sysop.]

    Amgen rose 1 1/2 to 63 3/4 on volume of 832,100 shares.
 The Food and Drug Administration approved use of the
 company's recombinant human erythropoietin product in
 treating anemia in AIDS patients.  Some patients develop
 anemia in conjunction with use of the drug AZT.  The Amgen
 product will be distributed by Johnson & Johnson's Ortho
 Pharmaceutical unit.

[This article is made available here by Dow Jones Co. for the 
personal and non-commercial use of callers to this bbs, in the 
hope that it will be of some help to those who are suffering 
from the disease and others who are seeking to help them.]